Clinical Trial: Safety and Clinical Performance of the LENTIS(R) MAX LS-313 MF80 Compared With the Monofocal L-313 in Cataract Patients With Late Age-Related Macular Degeneration: A Multicenter Comparative Clinical Investigation.

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915076) titled 'Safety and Clinical Performance of the LENTIS(R) MAX LS-313 MF80 Compared With the Monofocal L-313 in Cataract Patients With Late Age-Related Macular Degeneration: A Multicenter Comparative Clinical Investigation.' on Oct. 19.

Brief Summary: The goal of this clinical trial is to evaluate the safety, visual performance, and potential clinical benefits of the LENTIS(R) MAX LS-313 MF80 intraocular lens compared with the monofocal LENTIS(R) L-313 intraocular lens in adult patients with cataract in both eyes and clinically stable or inactive late age-related macular degeneration.

The main questions it aims to answer are:

1. Is corrected...